In the wake of having issued a series of guidances in the latter part of 2014 to enable implementation of the 2013 Drug Supply Chain Security Act (DSCSA), FDA is now concentrating on: ? reviewing the comments and finalizing the guidances ? issuing required regulations ? scheduling public meetings ? performing a supply chain pilot program, and ? developing a licensing program for the various trading partners in the supply chain.
展开▼
